Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate. (2017)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.14265
PubMed Identifier: 28036268
Publication URI: http://europepmc.org/abstract/MED/28036268
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncotarget
Issue: 4
ISSN: 1949-2553